Rosti Group highlights cutting-edge medical solutions at Medical Fair Asia 2026

The recently concluded Medical Fair Asia 2026, Southeast Asia’s Leading International Healthcare Trade Fair for the medical and healthcare sectors, provided opportunities for leading companies to unveil their products and services for this dynamic regional market. Held from 9-11 September in Singapore, Medical Fair Asia featured equipment and supplies for the pharmaceutical, medical and rehabilitation sectors and brought together healthcare professionals, medical device manufacturers, suppliers and industry leaders from around the world. 

ROSTI Group, represented by Rosti Asia Integrated Solutions Pte Ltd, demonstrated its extensive experience in medical device and healthcare product manufacturing at the exhibition. Highlighted at the exhibition was ROSTI’s capabilities ranging from precision injection moulding, cleanroom manufacturing, product assembly and integrated manufacturing solutions.

At the ROSTI booth, Melvin Tan, Vice President-Sales Asia, discussed how ROSTI has been supporting customers in the region in developing and producing healthcare products that meet the most stringent standards in this industry.

Melvin Tan, Vice President-Sales Asia, Rosti Asia Integrated Solutions Pte Ltd 

 (Image: ROSTI Group)

Innovations for Southeast Asia’s fast-growing medical sector

As a highly dynamic region, Southeast Asia is experiencing significant growth in medical and pharmaceutical products manufacturing, driven by rising consumer purchasing power, advances in production technologies and favourable government incentives.

ROSTI’s medical solutions presented at the Medical Fair Asia are based on four pillars: customer centricity, global footprint, operational excellence, and willingness to invest. As Melvin Tan puts it: “As far as customer centricity is concerned, we focus primarily on ensuring that we participate actively in our customer’s product development – from concept to reality. For medical product design, ROSTI provides case design, prototyping, 3D printing and also some of the samples that we can turn around within 72 hours.”  He also stressed how ROSTI supports its customers in process technology since the medical industry has stringent process control and standards. ROSTI’s strong capabilities in plastic injection moulding and the application of sustainable materials are advantages that would benefit customers in their medical manufacturing requirements, according to Melvin.

Countries in the region are adopting more stringent standards for medical and pharmaceutical products that compliance must be part of the game plan of manufacturers. As Melvin explained, ROSTI has an ISO Class 8 cleanrooms to make sure that ROSTI is able to manufacture the products designed or built for its customers. “In every innovation that we bring to our customer’s device, the whole process has been well documented – starting from the design, material control, traceability and actual production. It is very important to make sure that when we design and launch a product for our customers, our sites understand what is expected out of this product and then we are ready to go. These are all part of ROSTI’s innovations.”

Representatives of the ROSTI Group at Medical Fair Asia 2026  (Image: ROSTI Group)

Navigating today’s demand markets for medical devices

Today’s medical device requirements are evolving with faster turnaround time being demanded from manufacturers. In this aspect, ROSTI has successfully navigated market changes through its research and development strategy that enables it to evolve quickly and abide by the regulations. “Because regulation is getting tighter, we need to strike a balance on market changes plus regulation. As I mentioned, the concept  to reality is not just a slogan but making sure that we are able to control everything in-house – from the design to tooling and moulding up to the rest of the process. This helps us navigate in this market because we understand the customer's requirement while making sure that we are in compliance with the regulations.”

ROSTI employs a technical team composed of experienced professionals in polymer engineering. Hence, different types of materials are studied, while sustainability is also taken as a critical aspect. Also, given the material of choice, the ROSTI team ensures that it will be able to work with tooling, mold and all other aspects of production to meet the customer’s requirement. 

Across Asia, ROSTI has been offering a full concept of value chain, according to Melvin. This covers not only designing the product and production process but the whole value chain where ROSTI works in partnership with the customer and understands the whole supply chain management required to successfully produce the medical device. 

“Supply chain resilience is very important right now - world-class manufacturing and logistics – and ROSTI is trying to manage not just concept of value, but the whole product lifecycle management, making sure that products are delivered on time,” according to Melvin.   

Currently, ROSTI operates customer care centres in all its Asian sites – China, Malaysia, India and Singapore – providing customers with faster and more efficient response. “ROSTI has its presence in different sites in Asia and one of them is in Suzhou, China where ROSTI has its largest site in Asia. This site has evolved to become an important medical manufacturing hub housing ROSTI’s innovation centre, and it actually performs full contract manufacturing. Our Malaysia and India site achieved high level of manufacturing expertise to work with customers in this region,” Melvin added.  

When asked about the sustainability target, Melvin explained that sustainability has been built into ROSTI’s design and manufacturing process. The company has been able to reduce its greenhouse gas emissions by 44% since 2023 with the goal of making significant progress toward cutting those emissions by half in 2030.

For ROSTI, market challenges are opportunities to further enhance its innovative spirit. In Southeast Asia and globally, customers confidence can be achieved through a strong partnership founded on providing reliable, highly efficient design and manufacturing services aligned with the dynamic medical and pharmaceutical industry. 

About Rosti Group

Founded in 1944 with headquarters in Malmö, Sweden, the Group has 2,700 existing employees across thirteen facilities in the United States, Europe, and Asia. A global plastics injection moulding company and contract manufacturer to some of the world’s leading manufacturers in the packaging, consumer appliances, business machines, and medical sectors, Rosti is dedicated to providing leading-edge solutions “From concept to reality” to help customers create better components, processes and solutions. Rosti is owned by the family-controlled investment company Nordstjernan. Please visit: http://www.rosti.com